The estimated Net Worth of Trae Fitzgerald is at least $1.17 millió dollars as of 9 May 2024. Mr. Fitzgerald owns over 1,157 units of Viemed Healthcare Inc stock worth over $496,750 and over the last 4 years he sold VMD stock worth over $0. In addition, he makes $677,325 as Chief Financial Officer at Viemed Healthcare Inc.
Sign up
Mr. Fitzgerald VMD stock SEC Form 4 insiders trading
Trae has made over 8 trades of the Viemed Healthcare Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 1,157 units of VMD stock worth $8,504 on 9 May 2024.
The largest trade he's ever made was exercising 28,302 units of Viemed Healthcare Inc stock on 4 January 2021 worth over $208,020. On average, Trae trades about 7,444 units every 111 days since 2021. As of 9 May 2024 he still owns at least 67,585 units of Viemed Healthcare Inc stock.
You can see the complete history of Mr. Fitzgerald stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Trae Fitzgerald biography
Trae Paul Fitzgerald serves as Chief Financial Officer of the Company. He is a Chief Financial Officer of Viemed. Finance Manager of PHM until December 2017. Manager of Financial Reporting of PetroQuest Energy, Inc. Senior Accountant at Ernst and & Young.
What is the salary of Trae Fitzgerald?
As the Chief Financial Officer of Viemed Healthcare Inc, the total compensation of Trae Fitzgerald at Viemed Healthcare Inc is $677,325. There are 6 executives at Viemed Healthcare Inc getting paid more, with Casey Hoyt having the highest compensation of $2,167,640.
What's Trae Fitzgerald's mailing address?
Trae's mailing address filed with the SEC is 625, East Kaliste Saloom Road, Walroy, Lafayette, Lafayette Parish, Louisiana, 70508, United States.
Insiders trading at Viemed Healthcare Inc
Over the last 4 years, insiders at Viemed Healthcare Inc have traded over $0 worth of Viemed Healthcare Inc stock and bought 2,820 units worth $19,966 . The most active insiders traders include Casey Hoyt, Michael Moore és William Todd Zehnder. On average, Viemed Healthcare Inc executives and independent directors trade stock every 17 days with the average trade being worth of $133,432. The most recent stock trade was executed by Bruce D Greenstein on 25 August 2024, trading 10,719 units of VMD stock currently worth $78,785.
What does Viemed Healthcare Inc do?
viemed is a respiratory disease management company. our mission is to educate, nurture, and inspire our patients to lead better lives. we accomplish this through a highly effective home treatment model that integrates easily into the processes of our referral partners to effectively transition patients from the hospital to their home or other long-term care setting. while our respiratory care practitioners, trained as copd educators, deliver therapy and counseling to patients in their home utilizing the most effective technology available, our care consultants work with hospitals, aco’s, snf’s and other referral sources to simplify the administrative process of transitioning patients from hospital to home care. we achieve industry leading outcomes in hospital readmissions and patient satisfaction which has resulted in us becoming one of the largest home non-invasive ventilation providers in the usa.
What does Viemed Healthcare Inc's logo look like?
Complete history of Mr. Fitzgerald stock trades at Viemed Healthcare Inc
Viemed Healthcare Inc executives and stock owners
Viemed Healthcare Inc executives and other stock owners filed with the SEC include:
-
Casey Hoyt,
Chief Executive Officer, Director -
W. Todd Zehnder,
Chief Operating Officer, Director -
Casey Hoyt,
CEO & Director -
Michael B. Moore,
Pres -
William Todd Zehnder,
COO & Director -
Michael B. Moore CRT,
Pres -
Trae Fitzgerald,
Chief Financial Officer -
Jerome Cambre,
Vice President of Sales -
Trae Paul Fitzgerald,
Chief Financial Officer -
Jerome Richard Cambre II,
VP of Sales -
Timothy Smokoff,
Independent Director -
Nitin Kaushal,
Independent Director -
Bruce Greenstein,
Independent Director -
Randy Dobbs,
Independent Chairman of the Board -
William Frazier,
Chief Medical Officer, Director -
Dr. William Dana Frazier M.D.,
Chief Medical Officer & Director -
Glen Akselrod,
IR Contact Officer -
Robert Grossman LLB,
Corp. Sec. -
Patrick Eagan,
Gen. Counsel -
Rob Birkhead,
Chief Marketing Officer -
Brett Stoute,
Chief Compliance Officer -
Claudio Munoz,
Chief Information Officer -
John Collier,
Chief Technology Officer -
Dr. William Dana Frazier,
Chief Medical Officer & Director -
Jeremy Trahan,
General Counsel -
Sabrina Heltz,
Director -
Michael Moore,
President -
Ewell Patrick Eagan,
General Counsel